Although originally developed to treat type 2 diabetes, Ozempic is now prescribed for weight loss due to its active ingredient, semaglutide, which mimics the hormone GLP-1 (glucagon-like peptide-1)
After six months, body weight reduces by 30 percent and the weight loss continues up to two years
"We are pleased the court rejected compounders' attempts to undermine FDAs data-based decision," said Steve Benz, general counsel at Novo Nordisk
Future efforts should prioritize patient stratification, cost reduction, accessibility, and robust safety monitoring to fully harness the benefits of these groundbreaking therapies
Missing a single dose will not derail your progress
It has also been shown to slow gastric emptying, inhibit inappropriate post-meal glucagon release, and reduce food intake (table 1 and figure 1) GLP-1 origin